NAV: 12 Dec 2024 | ₹76.40 |
Min. SIP amount | ₹500 |
Rating | 5 |
Fund size | ₹314.88Cr |
1Y | 3Y | 5Y | All | |
---|---|---|---|---|
Fund returns | 9.7% | 8.5% | 7.6% | 7.0% |
Category average | 9.1% | 5.6% | 6.2% | NA |
Rank with in category | 9 | 1 | 3 | NA |
Debt, Medium to Long Duration funds | Rating | 1Y | 3Y | Fund Size(Cr) |
---|---|---|---|---|
UTI Medium to Long Duration Fund Direct Growth | 5 | 9.7% | 8.5% | 314.88 |
Nippon India Income Fund Direct Growth | 3 | 10.0% | 6.9% | 427.04 |
ICICI Prudential Bond Fund Direct Plan Growth | 4 | 9.7% | 6.7% | 2,959.92 |
SBI Magnum Income Direct Plan Growth | 4 | 9.5% | 6.7% | 1,795.93 |
HDFC Income Direct Plan Growth | 3 | 10.2% | 6.2% | 856.91 |
Name | Sector | Instrument | Assets |
---|---|---|---|
GOI | Sovereign | GOI Sec | 56.01% |
LIC Housing Finance Ltd. | Financial | Debenture | 8.05% |
HDB Financial Services Ltd. | Financial | Debenture | 7.90% |
Jamnagar Utilities and Power Pvt. Ltd. | Capital Goods | Debenture | 6.44% |
Aditya Birla Renewables Ltd. | Energy | Bonds/NCD | 4.80% |
Cholamandalam Investment and Finance Company Ltd. | Financial | NCD | 4.80% |
India Universal Trust AL1 | Others | Securitised Debt | 4.75% |
Rajasthan State | Others | SDL | 1.65% |
Maharashtra State | Others | SDL | 1.64% |
Mankind Pharma Ltd. | Healthcare | Bonds/Deb | 1.60% |
Clearing Corporation of India | Others | CP | 0.07% |
Inclusive of GST
Nil
0.005% (from July 1st, 2020)
Returns are taxed as per your Income Tax slab.
Min. for 1st investment | ₹500 |
Min. for 2nd investment onwards | ₹500 |
Min. for SIP | ₹500 |